RAP
Click for more information
0.00% 20.5¢ resapp health limited

BOD Motive?, page-3

  1. LeMetier
    62 Posts.
    lightbulb Created with Sketch. 33
    clock Created with Sketch.
    13/04/22
    07:44
    Post #: 60820135
    "Part of the agreement may have been the endorsement of the scheme by the board."

    My view also.

    Plus in an ideal world Pfizer want full control of the Resapp technology. Realising shareholders are unlikely to give it, they will accept the next best option, a partnership. Which is remarkable if true.
    RAP Price at posting: 11.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 17  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.